ISB News

100K Wellness Project Article by Lee Hood and Nathan Price in Clinical Omics

100K Wellness Project article in Clinical Omics written by ISB's Lee Hood and Nathan Price.

The latest press about the 100K Wellness Project is in the May 15 issue of Clinical Omics and features a piece by Dr. Lee Hood, president of Institute for Systems Biology (ISB), and Dr. Nathan Price, ISB’s associate director.

Read “Promoting Wellness and Demystifying Disease: The 100K Project

ISB's 100K Wellness Project featured in Clinical Omics Magazine. The article was written by Dr. Lee Hood and Dr. Nathan Price from Institute for Systems Biology.

ISB’s 100K Wellness Project featured in Clinical Omics Magazine. The article was written by Dr. Lee Hood and Dr. Nathan Price from Institute for Systems Biology.

Recent Articles

  • Co-corresponding author and ISB President Dr. Jim Heath and co-lead author Dr. Yapeng Su.

    For Cancer Cells, There Is More Than One Path to Drug Resistance

    In findings published in the journal Nature Communications, researchers show that cancer cells can take more than one path to reach a drug-resistant cell state. These findings could have promising implications for the future of cancer care.

  • ISB researchers

    Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis

    ISB researchers have unveiled new insights on how Mycobacterium tuberculosis, the pathogen that causes tuberculosis, enters and exits a dormant state in human hosts. About a quarter of the world’s population has latent TB, so these important findings will enable and accelerate the discovery of more effective TB drugs.

  • Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection

    Merck is collaborating with ISB and its partners to analyze blood samples and nasal swabs from Swedish Medical Center patients with SARS-CoV-2. Blood samples will be examined using proteomic, metabolomic, transcriptomics and genetic techniques to evaluate the impact of infection on different organs, and to identify potential biomarkers to predict the risk of severe disease.